CLINICAL_TRIALS
trial_result
· 2016-02-10
Clinical Trial Update: BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Summary
This document reports the completion of a Phase 1 trial of BAY 43-9006 (sorafenib) in patients with previously untreated non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED